ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1351

Development of Noninvasive Assessment Technology for Rheumatoid Arthritis Based on Contact Property Measurements

Woo-Joong KIM1, Chanseok PARK2, Seungmo KOO2, Jae-Young CHEONG2 and Jiho KIM2, 1Chung-Ang University Hospital, Seoul, Korea, Seoul, Republic of Korea, 2Hongik University, Seoul, Korea, Seoul, Republic of Korea

Meeting: ACR Convergence 2024

Keywords: Assistive devices, Disease Activity, Measurement Instrument, rheumatoid arthritis, Synovitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: RA – Diagnosis, Manifestations, & Outcomes Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Rheumatoid arthritis (RA) is a chronic inflammatory disease that requires regular monitoring to prevent joint damage and systemic complications. However, the shortage of trained rheumatologists and limited access to advanced assessment tools, such as ultrasonographic examinations, in many areas hinder effective disease management. This study aims to develop a noninvasive technology for on-site assessment of RA synovitis.

Methods: Based on the fact that synovial tissue inflammation causes changes in the mechanical properties within joints, we developed a compact, portable indentation device to measure the contact properties of synovial joints and monitor changes in intraarticular mechanics caused by synovitis. As a preliminary test, we created a model synovium using a hydrogel membrane with varying amounts of injected water to mimic different states of synovitis. A gentle oscillatory indentation is applied to the model to measure the contact viscoelasticity.

Results: The viscoelastic phase angle measured by the device increases with the amount of water injected into the model synovium, indicating that the device can distinguish the severity of synovitis and monitor RA disease activity. Furthermore, the phase angle increases with oscillatory indentation depth, indicating that the device captures the internal properties within the membrane when the indentation is deep enough. This suggests the necessary operating conditions for performing oscillatory measurements on the surface of the skin.

Conclusion: This approach quantifies RA synovitis based on the viscoelastic properties, which can potentially be integrated with artificial intelligence. This will significantly advance RA management, particularly in resource-limited settings. The device’s versatility and ease of use allow it to aid providers in tracking disease activity longitudinally, diagnosing RA flares, and adjusting treatment strategies accordingly.

Supporting image 1

Schematic of the indentation device to measure the contact properties of synovial joints .


Disclosures: W. KIM: None; C. PARK: None; S. KOO: None; J. CHEONG: None; J. KIM: None.

To cite this abstract in AMA style:

KIM W, PARK C, KOO S, CHEONG J, KIM J. Development of Noninvasive Assessment Technology for Rheumatoid Arthritis Based on Contact Property Measurements [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/development-of-noninvasive-assessment-technology-for-rheumatoid-arthritis-based-on-contact-property-measurements/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/development-of-noninvasive-assessment-technology-for-rheumatoid-arthritis-based-on-contact-property-measurements/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology